Aspire Biopharma Holdings Inc (ASBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 28 | 4 | 2 | 0 | 0 |
| Cost of Goods | 23 | 5 | 1 | N/A | N/A |
| Gross Profit | 6 | -1 | 1 | N/A | N/A |
| Operating Expenses | 1,675 | 1,854 | 1,147 | 800 | 15,557 |
| Operating Income | -1,646 | -1,849 | -1,146 | -800 | -15,557 |
| Interest Expense | 1,595 | 6,233 | 1,480 | 528 | 290 |
| Other Income | 19 | 3,375 | 775 | -654 | -95 |
| Pre-tax Income | -3,223 | -4,708 | -1,851 | -1,981 | -15,941 |
| Net Income Continuous | -3,223 | -4,708 | -1,851 | -1,981 | -15,941 |
| Net Income | $-3,223 | $-4,708 | $-1,851 | $-1,981 | $-15,941 |
| EPS Basic Total Ops | -20.57 | 109.08 | -48.05 | -48.05 | -504.88 |
| EPS Basic Continuous Ops | -20.57 | 106.23 | -44.88 | -48.24 | -504.87 |
| EPS Diluted Total Ops | -20.57 | 109.08 | -48.05 | -48.05 | -504.88 |
| EPS Diluted Continuous Ops | -20.57 | 106.23 | -44.88 | -48.24 | -504.87 |
| EPS Diluted Before Non-Recurring Items | -20.57 | N/A | -48.05 | -48.05 | -504.50 |
| EBITDA(a) | $-62 | $4,149 | $-1,146 | $-800 | $-15,557 |